Article
Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.
Antiviral research - 1 Apr 2014
Ogawa Eiichi, Furusyo Norihiro, Kajiwara Eiji, Nomura Hideyuki, Dohmen Kazufumi, Takahashi Kazuhiro, Nakamuta Makoto, Satoh Takeaki, Azuma Koichi, Kawano Akira, Tanabe Yuichi, Kotoh Kazuhiro, Shimoda Shinji, Hayashi Jun
Abstract excerpt
Elevated serum low-density lipoprotein cholesterol (LDL-C) level has been associated with sustained virological response (SVR) by chronic hepatitis C patients treated with pegylated-interferon (PEG-IFN) α and ribavirin (RBV). The aim of this study was to investigate the relation between the baseline LDL-C level and the treatment outcome from telaprevir (TVR)-based triple therapy. This prospective, multicenter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
